©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Rheumatol. Jul 12, 2015; 5(2): 96-100
Published online Jul 12, 2015. doi: 10.5499/wjr.v5.i2.96
Ins and outs of Helicobacter pylori association with autoimmune rheumatic diseases
Jibran Sualeh Muhammad, Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, Toyama 930-0914, Japan
Syed Faisal Zaidi, Department of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University of Health Sciences, Jeddah 21423, Saudi Arabia
Muhammad Ishaq, Department of Internal Medicine, Jinnah Medical College Hospital, Korangi, Karachi 74000, Pakistan
Author contributions: Muhammad JS designed research, performed research; wrote the paper; Zaidi SF and Ishaq M critically reviewed and corrected the manuscript; all authors have approved the final manuscript.
Conflict-of-interest statement: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Jibran Sualeh Muhammad, Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. email@example.com
Telephone: +81-80-42501703 Fax: +81-76-4345027
Received: November 6, 2014
Peer-review started: November 10, 2014
First decision: December 26, 2014
Revised: January 28, 2015
Accepted: March 30, 2015
Article in press: April 4, 2015
Published online: July 12, 2015
Rheumatic diseases (RD) include disorders related to joints and connective tissue. Generally these disorders have an autoimmune origin that is associated with progressive disability, systemic complications and early death. Involvement of musculoskeletal system, central and peripheral nervous systems, and other organs such as blood vessels, bone marrow, eye, heart, kidneys, lungs, skin and salivary glands may occurs in more than 40% of patients with RD over a lifetime of disease[1-3].
Typically initial Helicobacter pylori (H. pylori) infection is acquired by oral ingestion during the early childhood and H. pylori will persist for life in untreated cases. Frequency of H. pylori infection is approximately 80% in underdeveloped countries compared to 50% in developed parts of the world, correlating the disease prevalence with poor socioeconomic status. Clinically H. pylori infection leads to gastric diseases such as gastric ulcer, mucosa-associated lymphoid tissue lymphoma and gastric cancer. H. pylori infection can induce a chronic immune response in the host cells (Figure 1), suggesting a possible role of H. pylori in the development of autoimmune disorders.
Figure 1 Helicobacter pylori mediated immunologic responses.
IL: Interleukin; TNF: Tumor necrosis factor; H. pylori: Helicobacter pylori; DNA: Deoxyribonucleic acid.
Autoimmune RD are thought to depend upon host genetic susceptibility interaction with environmental factors. Amongst various environmental factors, infections agents plays significant role and have been studied extensively. Infectious agents include bacteria, viruses and parasites. Out of all bacterial species implicated in non-organ specific autoimmune disorders, H. pylori have received much attention by researchers. The purpose of this study was to summarize the recent literature on selected RD with autoimmune pathophysiologic mechanisms, which shows positive or negative evidence in relation to H. pylori-associated autoimmune rheumatic disorders.
H. PYLORI -INDUCED IMMUNOLOGIC RESPONCE
H. pylori have evolved various survival mechanisms to combat harsh acidic gastric environment and to suppress host immune response. Urease is a key virulence factor of H. pylori which is required for bacterial colonization to gastric mucosa; also it is a potent immunogen that elicits a strong immune response. Urease also serves to promote bacterial motility by decreasing gastric mucous viscosity. In order to evade host innate immune response, the bacterium is also capable of altering its own cell wall antigens rendering antigens to relatively non-antigenic.
H. pylori Infection induces a number of immune responses in the host cell by bacterial adhesion to cells and leading to chronic inflammation (Figure 1). Pathogen can bind to class II major histocompatibility complex present on the cell membrane of gastric epithelial cells leading to apoptosis. CagA translocate inside the gastric epithelial cells to induce high levels of inflammatory cytokines such as IL-6, IL-8, IL-10 and TNF-α. The VacA protein interacts with lymphocytes resulting in blockage of IL-2-mediated T-lymphocyte proliferation.
A study by Jackson et al shows elevated C-reactive protein in chronic H. pylori infected patients. Few other reports have demonstrated that chronic H. pylori infection leads to activation and survival of B lymphocytes to produce rheumatoid factor (IgM), antisingle-stranded DNA (anti-ssDNA) and anti-double-stranded DNA (anti-dsDNA) antibody and antiphosphotadylcholine antibody[18,19]. Instead of clearing H. pylori, these antibodies result in the synthesis of anti-H+/K+-ATPase antibodies. These auto-reactive autoantibodies have been involved in the progress of atrophic gastritis. Complex and persistent interaction between host immune system and pathogen might cause immune dysregulation and consequent development of autoimmune RD in susceptible patients.
H. PYLORI-ASSOCIATED RHEUMATOID ARTHRITIS
Rheumatoid arthritis (RA) is an autoimmune chronic inflammatory disorder primarily of unknown origin. The arthritis in RA is symmetrical destructive polyarthritis affecting almost all joints of the body. Various environmental and genetic factors may contribute to disease onset and severity. Search for the role of microbial association with RA dates back to 19th century, and several viral and bacterial pathogens such as hepatitis C virus, parvovirus B19, Epstein-Barr virus (EBV), Proteus mirabilis, and Mycobacterium tuberculosis may have a role in its pathogenesis. However the role of H. pylori infection in the pathogenesis of RA is controversial.
A cohort study on RA patients showed 80.4% to be seropositive for H. pylori. However, this was not significantly different from the control group. A study from Japan by Tanaka et al reported 49.3% of RA patients to have H. pylori antibodies, which was lesser compared with the healthy population. Another Japanese study reported a much higher prevalence (61.4%) of H. pylori infection in RA patients. A study by Zentilin et al showed severity of RA in H. pylori seropositive patients and suggested improvement in clinical symptoms after H. pylori eradication.
A direct role of H. pylori infection in RA pathogenesis seems controversial. Besides studies given above, few in vitro studies also suggest association of H. pylori in development of autoimmunity in RA patients. Like Yamanishi et al found chronic stimulation of B cells due to urease produced by H. pylori. This ultimately leads to the generation of rheumatoid factor. But, on the other hand, the clinical evidence for association between RA and H. pylori infection is less substantial and inconclusive. Although RA patients have a high risk of developing peptic ulcer disease (PUD), but the abundant use of non-steroidal anti-inflammatory drugs in the RA patient may also contribute to the risk for PUD development. Furthermore, studies have shown that not only RA patients but also other connective tissue disease patients have a prevalence of H. pylori infection nearly similar to that of control group[25,26]. Hence, the overall data regarding the association of H. pylori infection with RA pathogenesis remains controversial. Further specific in vitro and large scale clinical trials are required to provide clear understanding of this relationship.
H. PYLORI-ASSOCIATED SYSTEMIC LUPUS ERYTHEMATOSUS
Systemic lupus erythematosus (SLE) is an autoimmune chronic inflammatory disease affecting multi-system. Immunologic abnormalities include the production of a number of autoantibodies, such as anti-dsDNA and anti-nuclear antibodies. A number of microorganisms such as parvovirus B19, EBV and cytomegalovirus are associated in the disease pathogenesis.
H. pylori prevalence has been studied in SLE patients, but unlike other infectious agents, results vary significantly in published literature. A study by Kalabay et al demonstrated similar frequency of H. pylori infection in SLE patients and control group. Also a study by Showji et al demonstrated that patients with SLE have lesser anti-H. pylori antibodies in contrast to patients with some other connective tissue diseases. However, Yamanashi et al have shown in-vivo induction of anti-single stranded DNA antibodies by H. pylori urease. In contrast to this evidence of SLE related antibody induction by H. pylori, fewer studies have shown protective role of H. pylori-infection in patients with SLE. Such as, Sawalha et al have compared 466 SLE patients to matched control showing lower anti-H. pylori sero-positivity in SLE patients (36.5%:42.9%). Furthermore, in this study African American old age sero-positive females developed SLE more frequently compared to sero-negative females. Hence suggesting that H. pylori-infection have a protective role in the development of SLE is specific to this population group.
H. PYLORI-ASSOCIATED FIBROMYALGIA
Fibromyalgia (FMG), a chronic pain disorder, is associated with widespread musculoskeletal pain, stiffness, fatigue, anxiety, cognitive dysfunction, sleep difficulties and depression. Etiology and pathogenesis of FMG remains unknown. Studies have evaluated association of FMG with bacterial and viral infection, however literature regarding specific role of H. pylori-infection in FMG development is inadequate. Microorganisms might contribute to the development of FMG by activation of inflammatory cytokines leading towards neuroendocrine abnormalities.
A study by Malt et al shows that about 33% of the subjects were H. pylori positive in both FMG and control group, therefore they concluded that H. pylori-infection was not associated with psychological changes in both diseased and control subjects. A recent study by Akkaya et al demonstrated an association of H. pylori-infection with FMG patients and compared to similar gender control group. The FMG patients demonstrated higher frequency of an anti-H. pylori antibody (IgG) was seen in when compared to the control group, (30.8% and 17.1% respectively. Further, amongst FMG patients’ depression and anxiety levels were not different between H. pylori-infected FMG patients or un-infected FMG patients.
The unique ability of H. pylori to chronically infect human gastric mucosa to activate inflammation and host immunological response suggests its role in autoimmune diseases. Associations with few autoimmune diseases are strong, whereas association of H. pylori infection with autoimmune RD remains controversial. To develop better understanding of H. pylori-association with RD further molecular and clinical research studies with larger sample sizes are warranted.
P- Reviewer: Agarwal V, Cavallasca JA, Enlander D, Martinez-Lostao L, Rothschild BM S- Editor: Tian YL L- Editor: A E- Editor: Jiao XK